All Curated Mutation Sites in HIV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HIV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All
  
IN
  
RT
  
LTR
  
CA
  
Gag
  
Nef
  
Env
  
gp120
  
gp160
  
gp41
  
gp140
  
MA
  
Pol
  
PR
  
Rev
  
Tat
  
Vpu
  
Vif
  
Vpr
  

Keyword: HIV Infections-32160290
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 32160290 204delA
gp120
Env
HIV Infections
D
G
R
L
View
2 32160290 375delS
gp120
Env
HIV Infections
D
G
R
L
View
3 32160290 426delM
gp120
Env
HIV Infections
D
G
R
L
View
4 32160290 434delM
gp120
Env
HIV Infections
D
G
R
L
View
5 32160290 475delM
gp120
Env
HIV Infections
D
G
R
L
View
6 32160290 A204G
gp120
Env
HIV Infections
D
G
R
L
View
7 32160290 A204L
gp120
Env
HIV Infections
D
G
R
L
View
8 32160290 A204P
gp120
Env
HIV Infections
D
G
R
L
View
9 32160290 A204S
gp120
Env
HIV Infections
D
G
R
L
View
10 32160290 A204T
gp120
Env
HIV Infections
D
G
R
L
View
11 32160290 A204V
gp120
Env
HIV Infections
D
G
R
L
View
12 32160290 G167N
gp120
Env
HIV Infections
D
G
R
L
View
13 32160290 I154V
gp120
Env
HIV Infections
D
G
R
L
View
14 32160290 I323T
gp120
Env
HIV Infections
D
G
R
L
View
15 32160290 I371V
gp120
Env
HIV Infections
D
G
R
L
View
16 32160290 K192T
gp120
Env
HIV Infections
D
G
R
L
View
17 32160290 K322A
gp120
Env
HIV Infections
D
G
R
L
View
18 32160290 L116F
gp120
Env
HIV Infections
D
G
R
L
View
19 32160290 L116I
gp120
Env
HIV Infections
D
G
R
L
View
20 32160290 L116Q
gp120
Env
HIV Infections
D
G
R
L
View
21 32160290 L134W
gp120
Env
HIV Infections
D
G
R
L
View
22 32160290 M426K
gp120
Env
HIV Infections
D
G
R
L
View
23 32160290 M426L
gp120
Env
HIV Infections
D
G
R
L
View
24 32160290 M426Q
gp120
Env
HIV Infections
D
G
R
L
View
25 32160290 M426R
gp120
Env
HIV Infections
D
G
R
L
View
26 32160290 M426S
gp120
Env
HIV Infections
D
G
R
L
View
27 32160290 M426T
gp120
Env
HIV Infections
D
G
R
L
View
28 32160290 M426V
gp120
Env
HIV Infections
D
G
R
L
View
29 32160290 M434I
gp120
Env
HIV Infections
D
G
R
L
View
30 32160290 M434T
gp120
Env
HIV Infections
D
G
R
L
View
31 32160290 M434V
gp120
Env
HIV Infections
D
G
R
L
View
32 32160290 M475I
gp120
Env
HIV Infections
D
G
R
L
View
33 32160290 M475K
gp120
Env
HIV Infections
D
G
R
L
View
34 32160290 S195N
gp120
Env
HIV Infections
D
G
R
L
View
35 32160290 S375H
gp120
Env
HIV Infections
D
G
R
L
View
36 32160290 S375I
gp120
Env
HIV Infections
D
G
R
L
View
37 32160290 S375K
gp120
Env
HIV Infections
D
G
R
L
View
38 32160290 S375L
gp120
Env
HIV Infections
D
G
R
L
View
39 32160290 S375M
gp120
Env
HIV Infections
D
G
R
L
View
40 32160290 S375N
gp120
Env
HIV Infections
D
G
R
L
View
41 32160290 S375R
gp120
Env
HIV Infections
D
G
R
L
View
42 32160290 S375T
gp120
Env
HIV Infections
D
G
R
L
View
43 32160290 V506A
gp120
Env
HIV Infections
D
G
R
L
View
44 32160290 V506L
gp120
Env
HIV Infections
D
G
R
L
View
Contents
Description

The table shows all curated mutation sites of HIV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.